Header Logo

Connection

RITSUKO KOMAKI to Benzimidazoles

Back to Details
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Benzimidazoles.
RITSUKO KOMAKI
Connection Strength
0.079
Benzimidazoles
  1. Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis. Clin Cancer Res. 2012 Mar 15; 18(6):1641-54.
    View in: PubMed
    Score: 0.079
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.